Crystal structure of (1,10-phenanthroline-κ2 N,N′)-bis(3-thiophenecarboxylato-κ2 O,O′)copper(II), C22H14N2O4S2Cu-Reference-Cited by-同舟云学术

Crystal structure of (1,10-phenanthroline-κ2 N,N′)-bis(3-thiophenecarboxylato-κ2 O,O′)copper(II), C22H14N2O4S2Cu

Published:2021-07-06 Issue:5 Volume:236 Page:1019-1020
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Zhang Zhongyu¹^ORCID,Men Xiaoxia¹,Han Bing¹,Sun Chunyan¹

Affiliation:

1. Shandong Provincial Engineering Laboratory of Novel Pharmaceutical Excipients, Sustained and Controlled Release Preparations, College of Medicine and Nursing, Dezhou University , Dezhou , 253000 , Shandong , China

Abstract

Abstract C22H14N2O4S2Cu, orthorhombic, Pbcn (no. 60), a = 20.171(7) Å, b = 9.684(3) Å, c = 10.372(4) Å, V = 2025.9(12) Å3, Z = 4, R gt (F) = 0.0334, wR ref (F 2) = 0.0908, T = 273.15 K.

Publisher

Walter de Gruyter GmbH

Subject

Inorganic Chemistry,Condensed Matter Physics,General Materials Science

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2021-0199/pdf

Reference10 articles.

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2004.

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

3. Newkome, G. R., Marston, C. R. Chemistry of heterocyclic compounds series. 110. cobalt-60. gamma.-irradiation: homolytic alkylation of methyl nicotinate. J. Org. Chem. 1985, 50, 4162–4163; https://doi.org/10.1021/jo00221a040.

4. Lage, H., Aki-Sener, E., Yalcin, I. High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs. Int. J. Canc. 2010, 119, 213–220; https://doi.org/10.1002/ijc.21792.

5. Wei, M., Peng, X., Xing, L., Dai, Y., Huang, R., Geng, M., Zhang, A., Ai, J., Song, Z. Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-n-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (fgfr) inhibitors. Eur. J. Med. Chem. 2018, 154, 9–28; https://doi.org/10.1016/j.ejmech.2018.05.005.